Novo Nordisk Stock Jumps. New Ozempic Data for Seniors Beats Rival Eli Lilly Medicine.

Core Insights - The drug Ozempic has been shown to reduce the risk of heart attack, stroke, and death by 23% in patients with Type 2 diabetes and cardiovascular disease compared to an older drug [1] Group 1 - Ozempic demonstrates significant efficacy in reducing cardiovascular risks [1]